SYNGILVIA

Welcome to the Brand page for “SYNGILVIA”, which is offered here for Medicines for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; pharmaceutical products for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; pharmaceutical preparations for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; medical preparations for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases; biological preparations for medical use for the treatment of neurological, neurodegenerative, neuromuscular and neuropathic diseases;.

Its status is currently believed to be active. Its class is unavailable. “SYNGILVIA” is believed to be currently owned by “PHARNEXT”.